Effect of Ultra-processed Versus Unprocessed Diets on Energy Metabolism
Launched by NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES (NIDDK) · Mar 19, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how eating ultra-processed foods (like packaged snacks and sugary drinks) compares to eating unprocessed foods (like fruits, vegetables, and whole grains) on our bodies' energy use and overall health. The goal is to understand how these different types of diets can affect metabolism, which is how our bodies convert food into energy.
To participate, you need to be an adult aged 18 to 60, in good health without diabetes, and have a stable weight for the past six months. If you join, you'll stay at the National Institutes of Health (NIH) for four weeks, where you'll receive three meals a day and can eat as much or as little as you want. Each week, the type of diet will change, and you'll take part in activities like exercise, metabolism assessments, and taste tests. Daily monitoring will help researchers see how these diets affect your body. It’s a unique opportunity to contribute to important research while learning more about your health!
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- • Provision of signed and dated informed consent form
- • Adults age 18-60 years, male and female
- • Weight stable (\< +/- 5 % body weight change over past 6 months) as determined by volunteer report
- • Body mass index (BMI) \> =20 kg/m2
- • Body weight \> = 53 kg
- • Able to complete daily bouts of stationary cycling at a moderate rate and intensity with a HR equal to or greater than 0.3(SqrRoot) (220-age-HRrest)+HRrest but not exceeding 0.4(SqrRoot) (220-age-HRrest)+HRrest and no signs of arrhythmia
- • Willingness to comply with all study procedures and Lifestyle Considerations for the duration of the study per the discretion of the PI.
- EXCLUSION CRITERIA:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- • Evidence of diseases or conditions that may influence appetite (e.g., cancer, diabetes, alterations of smell or taste post COVID-19), or other conditions at the discretion of the PI and/or study team).
- • Taking prescription medications or other drugs that may influence appetite (including, but not limited to, diet/weight-loss medication or other medications at the discretion of the PI and/or study team)
- • Positive pregnancy test or lactation as determined by volunteer report (women only)
- • Participating in a regular exercise program (\> 2h/week of vigorous activity) as determined by volunteer report
- • Hematocrit \< 37% (women only)
- • Hematocrit \< 40% (men only)
- • Caffeine consumption \> 300 mg/day as determined by volunteer report
- • Alcohol consumption \> 3 drinks per day for men or \> 2 drinks per day for women as determined by volunteer report
- • Regular use of tobacco (smoking or chewing), amphetamines, cocaine, heroin, or marijuana over past 6 months as determined by volunteer report. Subjects may also be excluded based on a urine drug test.
- • Psychological conditions as determined by volunteer report such as (but not limited to) eating disorders, depression, bipolar disorders, that would be incompatible with safe and successful participation in this study, as determined by investigators
- • Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, food allergies) or a reported dislike of a significant fraction of the study foods
- • Volunteers unwilling or unable to give informed consent
About National Institute Of Diabetes And Digestive And Kidney Diseases (Niddk)
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is a prominent research institution within the National Institutes of Health (NIH) dedicated to advancing scientific knowledge and promoting health in the areas of diabetes, endocrine and metabolic disorders, obesity, digestive diseases, and kidney diseases. Through rigorous clinical trials and innovative research initiatives, NIDDK aims to improve prevention, diagnosis, and treatment strategies, ultimately enhancing patient outcomes and quality of life. The institute fosters collaboration among researchers, healthcare professionals, and community stakeholders to drive impactful discoveries and translate findings into effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Patients applied
Trial Officials
Valerie L Darcey
Principal Investigator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials